Cargando…
Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species
Scedosporium and Lomentospora species are opportunistic filamentous fungi that cause localized and disseminated infections in immunocompetent and immunocompromised patients. These species are considered resistant fungi due to their low susceptibility to most current antifungal agents used in healthc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897528/ https://www.ncbi.nlm.nih.gov/pubmed/36735743 http://dx.doi.org/10.1371/journal.pone.0280964 |
_version_ | 1784882267848441856 |
---|---|
author | Rollin-Pinheiro, Rodrigo Xisto, Mariana Ingrid Dutra da Silva de Castro-Almeida, Yuri Rochetti, Victor Pereira Borba-Santos, Luana Pereira Fontes, Yasmin da Silva Ferreira-Pereira, Antonio Rozental, Sonia Barreto-Bergter, Eliana |
author_facet | Rollin-Pinheiro, Rodrigo Xisto, Mariana Ingrid Dutra da Silva de Castro-Almeida, Yuri Rochetti, Victor Pereira Borba-Santos, Luana Pereira Fontes, Yasmin da Silva Ferreira-Pereira, Antonio Rozental, Sonia Barreto-Bergter, Eliana |
author_sort | Rollin-Pinheiro, Rodrigo |
collection | PubMed |
description | Scedosporium and Lomentospora species are opportunistic filamentous fungi that cause localized and disseminated infections in immunocompetent and immunocompromised patients. These species are considered resistant fungi due to their low susceptibility to most current antifungal agents used in healthcare settings. The search for new compounds that could work as promising candidate antifungal drugs is an increasing field of interest. In this context, in the present study we screened the Pandemic Response Box(®) library (Medicines for Malaria Venture [MMV], Switzerland) to identify compounds with antifungal activity against Scedosporium and Lomentospora species. An initial screening of the drugs from this collection at 5 μM was performed using a clinical Scedosporium aurantiacum isolate according to the EUCAST protocol. Compounds with activity against this fungus were also tested against four other species (S. boydii¸ S. dehoogii, S. apiospermum and L. prolificans) at concentrations ranging from 0.078 to 10 μM. Seven compounds inhibited more than 80% of S. aurantiacum growth, three of them (alexidine, amorolfine and olorofim) were selected due to their differences in mechanism of action, especially when compared to drugs from the azole class. These compounds were more active against biofilm formation than against preformed biofilm in Scedosporium and Lomentospora species, except alexidine, which was able to decrease preformed biofilm about 50%. Analysis of the potential synergism of these compounds with voriconazole and caspofungin was performed by the checkerboard method for S. aurantiacum. The analysis by Bliss methodology revealed synergistic effects among selected drugs with caspofungin. When these drugs were combined with voriconazole, only alexidine and amorolfine showed a synergistic effect, whereas olorofim showed an antagonistic effect. Scanning electron microscopy revealed that alexidine induces morphology alterations in S. aurantiacum biofilm grown on a catheter surface. Reactive oxygen species production, mitochondrial activity and surface components were analyzed by fluorescent probes when S. aurantiacum was treated with selected drugs and revealed that some cell parameters are altered by these compounds. In conclusion, alexidine, amorolfine and olorofim were identified as promising compounds to be studied against scedosporiosis and lomentosporiosis. |
format | Online Article Text |
id | pubmed-9897528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-98975282023-02-04 Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species Rollin-Pinheiro, Rodrigo Xisto, Mariana Ingrid Dutra da Silva de Castro-Almeida, Yuri Rochetti, Victor Pereira Borba-Santos, Luana Pereira Fontes, Yasmin da Silva Ferreira-Pereira, Antonio Rozental, Sonia Barreto-Bergter, Eliana PLoS One Research Article Scedosporium and Lomentospora species are opportunistic filamentous fungi that cause localized and disseminated infections in immunocompetent and immunocompromised patients. These species are considered resistant fungi due to their low susceptibility to most current antifungal agents used in healthcare settings. The search for new compounds that could work as promising candidate antifungal drugs is an increasing field of interest. In this context, in the present study we screened the Pandemic Response Box(®) library (Medicines for Malaria Venture [MMV], Switzerland) to identify compounds with antifungal activity against Scedosporium and Lomentospora species. An initial screening of the drugs from this collection at 5 μM was performed using a clinical Scedosporium aurantiacum isolate according to the EUCAST protocol. Compounds with activity against this fungus were also tested against four other species (S. boydii¸ S. dehoogii, S. apiospermum and L. prolificans) at concentrations ranging from 0.078 to 10 μM. Seven compounds inhibited more than 80% of S. aurantiacum growth, three of them (alexidine, amorolfine and olorofim) were selected due to their differences in mechanism of action, especially when compared to drugs from the azole class. These compounds were more active against biofilm formation than against preformed biofilm in Scedosporium and Lomentospora species, except alexidine, which was able to decrease preformed biofilm about 50%. Analysis of the potential synergism of these compounds with voriconazole and caspofungin was performed by the checkerboard method for S. aurantiacum. The analysis by Bliss methodology revealed synergistic effects among selected drugs with caspofungin. When these drugs were combined with voriconazole, only alexidine and amorolfine showed a synergistic effect, whereas olorofim showed an antagonistic effect. Scanning electron microscopy revealed that alexidine induces morphology alterations in S. aurantiacum biofilm grown on a catheter surface. Reactive oxygen species production, mitochondrial activity and surface components were analyzed by fluorescent probes when S. aurantiacum was treated with selected drugs and revealed that some cell parameters are altered by these compounds. In conclusion, alexidine, amorolfine and olorofim were identified as promising compounds to be studied against scedosporiosis and lomentosporiosis. Public Library of Science 2023-02-03 /pmc/articles/PMC9897528/ /pubmed/36735743 http://dx.doi.org/10.1371/journal.pone.0280964 Text en © 2023 Rollin-Pinheiro et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rollin-Pinheiro, Rodrigo Xisto, Mariana Ingrid Dutra da Silva de Castro-Almeida, Yuri Rochetti, Victor Pereira Borba-Santos, Luana Pereira Fontes, Yasmin da Silva Ferreira-Pereira, Antonio Rozental, Sonia Barreto-Bergter, Eliana Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species |
title | Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species |
title_full | Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species |
title_fullStr | Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species |
title_full_unstemmed | Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species |
title_short | Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species |
title_sort | pandemic response box(®) library as a source of antifungal drugs against scedosporium and lomentospora species |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897528/ https://www.ncbi.nlm.nih.gov/pubmed/36735743 http://dx.doi.org/10.1371/journal.pone.0280964 |
work_keys_str_mv | AT rollinpinheirorodrigo pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies AT xistomarianaingriddutradasilva pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies AT decastroalmeidayuri pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies AT rochettivictorpereira pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies AT borbasantosluanapereira pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies AT fontesyasmindasilva pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies AT ferreirapereiraantonio pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies AT rozentalsonia pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies AT barretobergtereliana pandemicresponseboxlibraryasasourceofantifungaldrugsagainstscedosporiumandlomentosporaspecies |